All filters
Abstracts
Short-Cycle Therapy in HIV-infected adults: 4 days on / 3 days off with combinations containing rilpivirine
D. Luise Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Perceptions, preferences and access to community-based HIV testing services among Men who have Sex with Men (MSM) in Côte d'Ivoire
M. Inghels Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Index-linked HIV testing for children and adolescents in health facility and community-based settings in Zimbabwe: Findings from the B-GAP study
C. Dziva Chikwari Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Striving towards HIV epidemic control through reaching a population in correctional facilities in Namibia
H. Ashivudhi Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Stakeholder participation in the establishment of One-stop shops and Key Population-friendly facilities: descriptive lessons from the FHI 360 GF project
C. Oraelosi Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Intensified Active tracking of clients lost to follow-up from HIV Care: Experiences from an HIV program in south-central Uganda.
Kisakye Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Organisation du financement du dépistage du VIH à base communautaire en Côte d'Ivoire : une recherche d'efficience potentiellement contre-productive?
A. Assoumou Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Cost of antiretroviral therapy services among patients who achieved viral suppression: A case study of 9 ART clinics in Namibia
N. Hamunime Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Using a Quality Improvement Collaborative Approach to Improve Tuberculosis prevention therapy coverage in the Kavango region, Namibia.
A. Basenero Reviews in Antiviral Therapy & Infectious Diseases 10, 2020  
Presented at:
INTEREST 2020
Abstracts
Case Series of Urethrocutaneous Fistulas After Voluntary Medical Male Circumcision for HIV Prevention—15 African Countries, 2015–2019
T. Lucas Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Association between DREAMS interventions and HIV risk behaviors of young women’s male sex partners in Rakai, Uganda
A. Ssettuba Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Traditional healers can increase uptake of HIV testing among adults of unknown serostatus: results from a cluster randomized pilot study in southwestern Uganda
R. Sundararajan Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Positive Effects of Intensified Preventive Calls/Home Visits on Early Retention Among Adults Newly Initiated on Antiretroviral Therapy in Zambézia Province, Mozambique
C. De Schacht Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
DTG+3TC vs DTG+TDF/FTC (GEMINI-1&-2): Confirmed Virologic Withdrawals Through Week 96
J. van Wyk Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Does Dolutegravir causes weight gain: a retrospective observational cohort study from Lusaka, Zambia
D. Mwamba Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: 96-week results of the ANRS 12313 – NAMSAL trial
C. Kouanfack Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Effectiveness of male Strategy (MS) in HIV case identification and linkage of MLHIV to treatment in Cameroon.
E. Njemkerk Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO Study
J. van Wyk Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020